These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12015922)

  • 1. [The Ravel trial. Zero percent restenosis: A cardiologists dream comes true!].
    Regar E; Serruys PW
    Rev Esp Cardiol; 2002 May; 55(5):459-62. PubMed ID: 12015922
    [No Abstract]   [Full Text] [Related]  

  • 2. Stenting for small coronary vessels: a contestable winner.
    Kastrati A; Schühlen H; Schömig A
    J Am Coll Cardiol; 2001 Nov; 38(6):1604-7. PubMed ID: 11704370
    [No Abstract]   [Full Text] [Related]  

  • 3. [Drug-eluting stents do they make the difference? ].
    Presbitero P; Asioli M
    Minerva Cardioangiol; 2002 Oct; 50(5):431-42. PubMed ID: 12384625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Coronary stents].
    Amann FW
    Ther Umsch; 2003 Apr; 60(4):179-82. PubMed ID: 12731426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiographic findings of the multicenter Randomized Study With the Sirolimus-Eluting Bx Velocity Balloon-Expandable Stent (RAVEL): sirolimus-eluting stents inhibit restenosis irrespective of the vessel size.
    Regar E; Serruys PW; Bode C; Holubarsch C; Guermonprez JL; Wijns W; Bartorelli A; Constantini C; Degertekin M; Tanabe K; Disco C; Wuelfert E; Morice MC;
    Circulation; 2002 Oct; 106(15):1949-56. PubMed ID: 12370218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-eluting stenting for unprotected left main coronary artery disease: are we ready to replace bypass surgery?
    Baim DS; Mauri L; Cutlip DC
    J Am Coll Cardiol; 2006 Feb; 47(4):878-81. PubMed ID: 16487859
    [No Abstract]   [Full Text] [Related]  

  • 7. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial.
    Kastrati A; Mehilli J; von Beckerath N; Dibra A; Hausleiter J; Pache J; Schühlen H; Schmitt C; Dirschinger J; Schömig A;
    JAMA; 2005 Jan; 293(2):165-71. PubMed ID: 15644543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lessons from the E-SIRIUS trial.
    Schofer J
    Ital Heart J; 2004 Jan; 5(1):1-2. PubMed ID: 15080572
    [No Abstract]   [Full Text] [Related]  

  • 9. [Drug-eluting stents: do they keep their promises?].
    Nordmann A
    Praxis (Bern 1994); 2006 Apr; 95(15):581-3. PubMed ID: 16640178
    [No Abstract]   [Full Text] [Related]  

  • 10. Coronary balloon angioplasty, stents, and scaffolds.
    Byrne RA; Stone GW; Ormiston J; Kastrati A
    Lancet; 2017 Aug; 390(10096):781-792. PubMed ID: 28831994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Through the drug-eluting stent labyrinth.
    Guagliumi G; Musumeci G; Vassileva A; Tespili M; Valsecchi O
    Ital Heart J; 2003 Apr; 4(4):236-45. PubMed ID: 12784776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A paclitaxel-eluting stent for the prevention of coronary restenosis.
    Park SJ; Shim WH; Ho DS; Raizner AE; Park SW; Hong MK; Lee CW; Choi D; Jang Y; Lam R; Weissman NJ; Mintz GS
    N Engl J Med; 2003 Apr; 348(16):1537-45. PubMed ID: 12700373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are drug-eluting stents the preferred treatment for multivessel coronary artery disease?
    Klein LW
    J Am Coll Cardiol; 2006 Jan; 47(1):22-6. PubMed ID: 16386659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Why the provisional single-stent approach is not always the right strategy; arguments for the development of dedicated bifurcation devices.
    Grundeken MJ; Stella PR; Wykrzykowska JJ
    EuroIntervention; 2012 Mar; 7(11):1249-53. PubMed ID: 22433188
    [No Abstract]   [Full Text] [Related]  

  • 15. The "0%" restenosis study.
    Colombo A
    Ital Heart J; 2002 Oct; 3(10):559-6. PubMed ID: 12478812
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prevention of postangioplasty restenosis].
    Kitai T; Ishiwata S; Yamaguchi T
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():627-31. PubMed ID: 12735042
    [No Abstract]   [Full Text] [Related]  

  • 17. [When are drug-eluting stents effective? A critical analysis of the presently available data].
    Silber S
    Z Kardiol; 2004 Sep; 93(9):649-63. PubMed ID: 15365732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economics of sirolimus-eluting stents: drug-eluting stents have really arrived.
    Weintraub WS
    Circulation; 2004 Aug; 110(5):472-4. PubMed ID: 15289386
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug-eluting stent: the emerging technique for the prevention of restenosis.
    Sheiban I; Carrieri L; Catuzzo B; Destefanis P; Oliaro E; Moretti C; Trevi GP
    Minerva Cardioangiol; 2002 Oct; 50(5):443-53. PubMed ID: 12384626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized comparison of J&J Crown stent versus NIR stent after routine coronary angioplasty.
    Miketic S; Carlsson J; Tebbe U
    Am Heart J; 2001 Nov; 142(5):E8. PubMed ID: 11685183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.